Rosti Strengthens Global Medical Manufacturing With New Cleanroom

Rosti has begun operating a new ISO Class 8 (Class 100,000) medical cleanroom at its China facility, further strengthening its global capabilities in high-precision medical manufacturing.

The newly established 500-square-meter cleanroom includes a dedicated 300-square-meter precision injection molding production area and has been developed in accordance with stringent medical industry standards. The investment supports Rosti’s continued expansion within the medical sector and enhances its ability to serve global medical and healthcare customers with reliable, compliant manufacturing solutions.

“The new cleanroom represents an important milestone in the development of Rosti China’s medical business,” Group Senior Vice President of Asia Pat Williams said.

Designed to enable the production of high-quality medical components under tightly controlled conditions, the new facility reflects Rosti’s long-term commitment to quality-driven manufacturing and specialized production environments, executives claim. The cleanroom strengthens local manufacturing capabilities while remaining fully aligned with Rosti’s global quality systems and operational standards.

“The investment enables the team to further support customers with high-standard medical manufacturing capabilities and continued focus on quality and performance,” Rosti China General Manager Sunny Sun stated.

The new cleanroom forms part of Rosti’s broader strategy to invest in advanced manufacturing infrastructure across key regions, supporting customer growth in regulated industries while maintaining consistent quality and scalability across its global footprint.

Rosti Group is a global plastic injection molding and contract manufacturing company, founded in 1944 and headquartered in Malmö, Sweden. With 2,500 employees and facilities across Europe, Asia, and the United States, Rosti delivers full-service solutions from design to delivery.